An 0.1% aqueous trypan blue solution was injected into the anterior chamber during cataract extraction for the purpose of disclosing endothelial cell damage if present. Follow-up examination of 24 patients after eight years revealed no side-effects of trypan blue, as judged by corneal opacities, compared with non-vital-stained aphakic and non-operated control eyes.
No takes yet. Share an insight, caveat, or question.
M. S. Norn (1980) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: